Amy Pauli
Overview
When highly regulated entities, such as food and beverage and consumer packaged goods companies, face Federal Trade Commission and manufacturing compliance risks, advertising and marketing disputes, competition concerns, or class action litigation, Amy Marie Pauli provides targeted, actionable counsel to quickly and efficiently minimize risk or resolve disputes. Amy works with category-leading companies to navigate outdated and murky regulatory requirements to help clients achieve product innovation goals. She is also a go-to advocate when regulated entities face class action disputes or seek an experienced appellate or amicus counsel.
Career & Education
- U.S. Court of Appeals for the Tenth Circuit
Judicial Clerk to the Hon. Gregory A. Phillips, 2017–2018
- U.S. Court of Appeals for the Tenth Circuit
- University of Wyoming, B.A., 2014
- University of Utah, J.D., highest honors, Order of the Coif, Executive Social Justice Editor, Utah Law Review, 2017
- Colorado
- Wyoming
- U.S. District Court for the District of Colorado
- U.S. Court of Appeals for the Tenth Circuit
Professional Activities and Memberships
- Member, Colorado Women’s Bar Association
- Board of Directors, Denver Urban Debate League
- Participant, LCLD 2021 Pathfinder Program
- Participant, Impact Denver Spring 2021 Program
Amy's Insights
Client Alert | 3 min read | 01.11.24
FDA Issues Final Guidance on Direct-to-Consumer Prescription Drug Advertisements
In late December, the FDA released a guidance document that provides clarity for small businesses marketing direct-to-consumer (DTC) drug products on television or radio. The Q&A followed the FDA’s November 2023 Final Rule amending DTC advertising regulations for prescription drugs.
Firm News | 9 min read | 08.17.23
Firm News | 2 min read | 07.17.23
Crowell & Moring Honors Recipients of 24th Annual George Bailey Public Service Awards
Firm News | 1 min read | 05.22.23
Representative Matters
- Consumer class actions. Secured complete dismissal of consumer class action for pet products manufacturer in the U.S. District Court for the Northern District of California. Plaintiff sought $5 million in damages and asserted claims including fraud, breach of warranty, and that the label was misleading under consumer protection statutes.
- Regulatory business disputes. Represented animal product manufacturer in investigation of regulatory defects in business acquired by client and litigation for breaches of acquisition agreement. Successfully brought federal court litigation alleging more than $7 million in damages, resulting in highly favorable settlement for client.
- Proposition 65. Serving as Proposition 65 counsel for nationwide chip brand, animal feed manufacturer, chocolate manufacturer, and consumer product brand.
- State dairy regulations. Providing state dairy regulations counsel to multinational ice cream company, global beverage company, and national dairy brand. Advising regarding distribution licensing and nationwide promotional and advertising matters, including couponing and associated regulations and requirements.
- Food labeling counseling. Advising global beverage brand regarding product launches, advertising and marketing risks, and bottle bill compliance for various product lines including juices, sodas and carbonated beverages, flavored waters, and energy drinks.
- Class and collective employment actions. Secured dismissal of State Department-regulated au pair agency from a putative class action in the Eastern District of New York and California state court. Plaintiffs asserted minimum wage and overtime violations of the Fair Labor Standards Act, state labor laws, and the Private Attorneys General Act.
Amy's Insights
Client Alert | 3 min read | 01.11.24
FDA Issues Final Guidance on Direct-to-Consumer Prescription Drug Advertisements
In late December, the FDA released a guidance document that provides clarity for small businesses marketing direct-to-consumer (DTC) drug products on television or radio. The Q&A followed the FDA’s November 2023 Final Rule amending DTC advertising regulations for prescription drugs.
Firm News | 9 min read | 08.17.23
Firm News | 2 min read | 07.17.23
Crowell & Moring Honors Recipients of 24th Annual George Bailey Public Service Awards
Firm News | 1 min read | 05.22.23
Practices
Industries
Amy's Insights
Client Alert | 3 min read | 01.11.24
FDA Issues Final Guidance on Direct-to-Consumer Prescription Drug Advertisements
In late December, the FDA released a guidance document that provides clarity for small businesses marketing direct-to-consumer (DTC) drug products on television or radio. The Q&A followed the FDA’s November 2023 Final Rule amending DTC advertising regulations for prescription drugs.
Firm News | 9 min read | 08.17.23
Firm News | 2 min read | 07.17.23
Crowell & Moring Honors Recipients of 24th Annual George Bailey Public Service Awards
Firm News | 1 min read | 05.22.23